---
layout: minimal-medicine
title: Colfosceril palmitate
---

# Colfosceril palmitate
### Generic Name
Colfosceril Palmitate

### Usage
Colfosceril palmitate is a lung surfactant primarily used in the prevention and treatment of respiratory distress syndrome (RDS) in newborn babies.  RDS is a serious condition affecting premature infants, characterized by insufficient surfactant in the lungs, leading to breathing difficulties.  Colfosceril palmitate helps to restore normal lung function by supplementing this missing surfactant.  It's specifically indicated for newborns weighing 700 grams or more who require mechanical ventilation.  This medication is not used in adults.

### Dosage
Colfosceril palmitate is administered intratracheally (directly into the trachea via an endotracheal tube).  Dosage varies depending on whether it's used for prophylaxis (prevention) or rescue treatment.

**Prophylaxis (Prevention):**  For newborns weighing 700 grams or more, three 5 mL/kg doses are recommended. The first dose is given as soon as possible after birth, with subsequent doses administered 12 and 24 hours later if the infant remains on mechanical ventilation.

**Rescue Treatment:** For newborns diagnosed with RDS, two 5 mL/kg doses are recommended. The first dose is given upon confirmation of RDS, and the second dose is given 12 hours later if the infant remains on mechanical ventilation.

**Dosage Adjustments:**  The manufacturer's labeling does not provide dosage adjustments for hepatic (liver) or renal (kidney) impairment.


### Side Effects
Common side effects (occurring in more than 1% of patients) may include:

*   Bradycardia (slow heart rate)
*   Tachycardia (fast heart rate)
*   Decreased oxygen saturation
*   Mucous plugging
*   Apnea (cessation of breathing)
*   Pulmonary hemorrhage (bleeding in the lungs)


Less common, but serious, side effects are possible.  It is crucial to monitor the infant closely for any adverse reactions.  Contact a healthcare provider immediately if any concerning side effects occur.

### How it Works
Colfosceril palmitate is a synthetic lung surfactant.  Surfactant is a complex mixture of lipids and proteins naturally produced in the lungs. It reduces the surface tension in the alveoli (tiny air sacs in the lungs), preventing their collapse during exhalation.  Premature infants often lack sufficient surfactant, leading to RDS. Colfosceril palmitate works by replacing this missing surfactant, improving lung compliance (the ability of the lungs to expand) and oxygenation (the uptake of oxygen into the blood). This allows the infant to breathe more easily.

### Precautions
Colfosceril palmitate is contraindicated in infants with major congenital abnormalities or suspected congenital infections.  The medication should be reconstituted immediately before use with the supplied diluent.  Close monitoring of the infant's heart rate, oxygen saturation, and respiratory status is essential during and after administration.  Adjustments to ventilator settings may be needed based on the infant's response.  The medication is not indicated for use in pregnant or breastfeeding women.


### FAQs

*   **Q: How is Colfosceril palmitate stored?** A: Storage conditions are not provided in the information but reconstitution and usage instructions indicate it has a shelf life of 12 hours after reconstitution. Always refer to the specific product labeling for accurate storage instructions.

*   **Q: What should I do if I miss a dose?** A:  This medication is administered by a healthcare professional in a hospital setting.  Any questions regarding missed doses should be directed to the infant's healthcare provider.

*   **Q: Are there any drug interactions?** A:  Information on specific drug interactions is not provided here.  Always inform your healthcare provider of all medications the infant is receiving to assess potential interactions.

*   **Q: Is Colfosceril palmitate safe for all newborns?** A: No, it is contraindicated in infants with major congenital abnormalities or suspected congenital infections.  Its use should be determined by a healthcare professional based on the infant's condition.



**Disclaimer:** This information is intended for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before starting or changing any medication.  The information provided here is based on the data provided and may not encompass all possible information about this medication.  Always refer to the official prescribing information for the most accurate and complete details.
